Abstract
The Sprague-Dawley rat is highly regarded for studies designed to investigate the effects of endocrine modulation on mammary carcinogenesis. In this study, we further evaluate the validity of the Sprague-Dawley rat model for the study of human breast cancer by evaluating the effects of normal 4-day estrous cycling on mammary epithelial cell proliferation, differentiation, and apoptotic death. Trends in mammary gland development with stage of 4-day estrous cycle were evident. Mammary glands isolated from follicular and early luteal stages had predominantly ductal histoarchitecture, whereas glands isolated from mid-late luteal were predominantly lobuloalveolar. Quantitation of BrdU incorporation revealed that epithelial cell proliferation was eight-fold higher in metestrus and diestrus-1 than in proestrus. Expression of β-casein and whey acidic protein (WAP)4 mRNA was also highly dependent on stage of estrous, with detection restricted to midcycle. Apoptotic cell death of mammary epithelium was found to be suppressed during the peak in cell proliferation. TRPM-2/clusterin mRNA was elevated when apoptosis was low and milk protein mRNA levels were high, consistent with putative roles for TRPM-2/clusterin in inhibiting cell death in regressing tissues and inducing mammary epithelial cell differentiation. Cell proliferation, differentiation, and death occurred only in a subset of epithelial cells per estrous cycle, and these cells appeared randomly distributed throughout multiple ductules and alveoli. These observations suggest that cellular response(s) to ovarian hormone-dependent signals is asynchronous. Cumulatively, these observations demonstrate that rat mammary epithelial cell proliferation, differentiation, and death are under the control of cycling ovarian hormones, similarly to the human mammary epithelium during the menstrual cycle.
Similar content being viewed by others
REFERENCES
P. H. Peeters, A. L. Verbeek, A. Krol, M. M. Matthyssen, and F. de Waard (1995). Age at menarche and breast cancer risk in nulliparous women. Breast Cancer Res. Treat. 33:55–61.
B. M. Sherman and S. G. Korenman (1974). Inadequate corpus luteum function: A pathophysiological interpretation of human breast cancer epidemiology. Cancer 33:1306–1312.
I. den Tonkelaar and F. de Waard (1996). Regularity and length of menstrual cycles in women aged 41–46 in relation to breast cancer risk: Results from the DOM-project. Breast Cancer Res. Treat. 38:253–258.
B. Rosner, G. A. Colditz, and W. C. Willett (1994). Reproductive risk factors in a prospective study of breast cancer: The nurses' health study. Am. J. Epidemiol. 139:819–835.
L. Titus-Ernstoff, M. P. Longnecker, P. A. Newcomb, B. Dain, E. R. Greenberg, R. Mittendorf, M. Stampfer, and W. Willett (1998). Menstrual factors in relation to breast cancer risk. Cancer Epidemiol. Biomarkers Prevent. 7:783–789.
S. G. Korenman (1980). Oestrogen window hypothesis of the aetiology of breast cancer. Lancet 1(8170):700–701.
B. E. Henderson, R. Ross, and L. Bernstein (1988). Estrogens as a cause of human cancer: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 48:246–253.
D. Roy and J. G. Liehr (1999). Estrogen, DNA damage and mutations. Mutat. Res. 424:107–115.
J. C. Sabourin, A. Martin, J. Baruch, J. B. Truc, A. Gompel, and P. Poitout (1994). bcl-2 expression in normal breast tissue during the menstrual cycle. Int. J. Cancer 59:1–6.
H. Fanger and H. J. Ree (1974). Cyclic changes of human mammary gland epithelium in relation to the menstrual cycle— An ultrastructural study. Cancer 34:574–585.
P. M. Vogel, N. G. Georgiade, B. F. Fetter, F. S. Vogel, and K. S. McCarty, Jr. (1981). The correlation of histologic changes in the human breast with the menstrual cycle. Am. J. Pathol. 104:23–34.
T. A. Longacre and S. A. Bartow (1986). A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am. J. Surg. Pathol. 10:382–393.
D. J. Ferguson and T. J. Anderson (1981). Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast. Br. J. Cancer 44:177–181.
T. J. Anderson, D. J. Ferguson, and G. M. Raab (1982). Cell turnover in the “resting” human breast: Influence of parity, contraceptive pill, age and laterality. Br. J. Cancer 46(3): 376–382.
C. S. Potten, R. J. Watson, G. T. Williams, S. Tickle, S. A. Roberts, M. Harris, and A. Howell (1988). The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br. J. Cancer 58:163–170.
J. A. Long and H. M. Evans (1922). The oestrous cycle in the rat and its associated phenomena. In A. O. Leuschner, (ed.), Memoirs of the University of California, Vol. 6, University of California Press, Berkeley, California.
J. Russo, M. J. Mills, M. J. Moussalli, and I. H. Russo (1989). Influence of human breast development on the growth properties of primary cultures. In Vitro Cell Dev. Biol. 27:643–649.
P. J. Schedin, R. Strange, M. Singh, M. R. Kaeck, S. C. Fontaine, and H. J. Thompson (1995). Treatment with chemopreventive agents, difluoromethylornithine and retinyl acetate, results in altered mammary extracellular matrix. Carcinogenesis 16:1787–1794.
B. Lloveras, S. Edgerton, and A. D. Thor (1991). Evaluation of in vitro bromodeoxyuridine labeling of breast carcinomas with the use of a commercial kit. Am. J. Clin. Pathol. 95:41–47.
P. Chromczynski and N. Sacchi (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal. Biochem. 162:156–159.
N. B. Schwartz (1969). A model for the regulation of ovulation in the rat. Rec. Prog. Horm. Res. 25:1–55.
N. B. Schwartz and P. Waltz (1970). Role of ovulation in the regulation of the estrous cycle. Fed. Proc. 29:1907–1912.
L. G. Nequin, W. L. Talley, B. G. Mann, and N. B. Schwartz (1974). Measurement of serumLHduring the proestrus critical period in rats exhibiting four-or five-day estrous cycles. Neuroendocrinology 14(2):65–71.
R. L. Butcher, W. E. Collins, and N. W. Fugo (1974). Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology 94:1704–1708.
P. S. Kalra and S. P. Kalra (1977). Temporal changes in the hypothalamic and serum luteinizing hormone-releasing hormone (LH-RH) levels and the circulating ovarian steroids during the rat oestrous cycle. Acta Endocrinol. (Copenh.) 85:449–455.
L. G. Nequin, J. Alvarez, and N. B. Schwartz (1979). Measurement of serum steroid and gonadotropin levels and uterine and ovarian variables throughout 4 day and 5 day estrous cycles in the rat. Biol. Reprod. 20:659–670.
P. S. Kalra and S. P. Kalra (1979). Regulation of gonadal steroid rhythms in rats. J. Steroid Biochem. 11(1C):981–987.
M. C. Pike, D. V. Spicer, L. Dahmoush, and M. F. Press (1993). Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol. Rev. 15:17–35.
G. Melino and M. Piacentini (1998). 'Tissue’ transglutaminase in cell death: A downstream or a multifunctional upstream effector? FEBS Lett. 430: 59–63.
R. Strange, F. Li, S. Saurer, A. Burkhardt, and R. R. Friis (1992). Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115:49–58.
L. E. French, J. V. Soriano, R. Montesano, and M. S. Pepper (1996). Modulation of clusterin gene expression in the rat mammary gland during pregnancy, lactation, and involution. Biol. Reprod. 55:1213–1220.
L. E. French, A. Whohlwend, A. P. Sappino, J. Tschopp, and J. A. Schifferli (1994). Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J. Clin. Invest. 93:877–884.
C. Koch-Brandt and C. Morgans (1996). Clusterin: A role in cell survival in the face of apoptosis? Prog. Mol. Subcell. Biol. 16:130–149.
C. B. Huggins (1987). Selective induction of hormonedependent mammary adenocarcinoma in the rat. J. Lab. Clin. Med. 109:262–266.
M. N. Gould (1993). Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in humans and rats. Semin. Cancer Biol. 4:161–169.
E. S. Rivera, N. Andrade, G. Martin, G. Melito, G. Cricco, N. Mohamad, C. Davio, R. Caro, and R. M. Bergoc (1994). Induction of mammary tumors in rat by intraperitoneal injection of NMU: Histopathology and estral cycle influence. Cancer Lett. 86:223–228.
H. J. Thompson, J. N. McGinley, K. Rothhammer, M. Singh (1995). Rapid induction of mammary intraductal proliferations, ductal carcinoma in situ and carcinomas by the injection of sexually immature female rats with 1-methyl-1-nitrosourea. Carcinogenesis. 16(10):2407–2411.
J. Russo and I. H. Russo (2000). Atlas and histologic classification of tumors of the rat mammary gland. J. Mammary Gland Biol. Neoplasia, this issue.
H. J. Thompson, M. Singh, and J. McGinley (2000). Classification of premalignant and malignant lesions developing in the rat mammary gland after injection of sexually immature rats with 1-methyl-1-nitrosourea. J. Mammary Gland Biol. Neoplasia, this issue.
S. Nandi, R. C. Guzman, and J. Yang (1995). Hormones and mammary carcinogenesis in mice, rats, and humans:Aunifying hypothesis. Proc. Natl. Acad. Sci. USA 92:3650–3657.
I. H. Russo and J. Russo (1996). Mammary gland neoplasia in long-term rodent studies. Environ. Health Perspect. 104: 938–967.
D. Kritchevsky (1997). Caloric restriction and experimental mammary carcinogenesis. Breast Cancer Res. Treat. 46: 161–167.
J. Russo, L. K. Tay, and I. H. Russo (1982). Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat. 2:5–73.
C. J. Grubbs, M. M. Juliana, D. L. Hill, and L. M. Whitaker (1986). Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland. Anticancer Res. 6:1395–1400.
R. C. Guzman, J. Yang, L. Rajkumar, G. Thordarson, X. Chen, and S. Nandi (1999). Hormonal prevention of breast cancer: Mimicking the protective effect of pregnancy. Proc. Natl. Acad. Sci. USA 96:2520–2525.
V. C. Jordan (1991). Chemosuppression of breast cancer with long-term tamoxifen therapy. Prevent. Med. 20:3–14.
M. S. Smith, M. E. Freeman, and J. D. Neill (1975). The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: Prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Endocrinology 96:219–226.
P. Mauvais-Jarvis, F. Kuttenn, and A. Gompel (1986). Estradiol/progesterone interaction in normal and pathologic breast cells. Ann. N. Y. Acad. Sci. 464:152–167.
A. C. Andres, G. Zuercher, V. Djonov, M. Flueck, and A. Ziemiecki (1995). Protein tyrosine kinase expression during the estrous cycle and carcinogenesis of the mammary gland. Int. J. Cancer 63:288–296.
B. Vonderhaar (1988). Regulation of development of the normal mammary gland by hormones and growth factors. In M. E. Lippman and R. Dickson (eds.), Breast Cancer: Cellular and Molecular Biology, Kluwer, Dordrecht, pp. 251–266.
G. W. Robinson, R. A. McKnight, G. H. Smith, and L. Hennighausen (1995). Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121:2079–2090.
H. J. Thompson, J. N. McGinley, P. Wolfe, M. Singh, V. E. Steele, and G. J. Kelloff (1998). Temporal sequence of mammary intraductal proliferations, ductal carcinomas in situ and adenocarcinomas induced by 1-methyl-1-nitrosourea in rats. Carcinogenesis 19:2181–2185.
H. J. Thompson, R. Strange, and P. J. Schedin (1992). Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol. Biomarkers Prevent. 1:597–602.
J. Steinberg, R. Oyasu, S. Lang, S. Sintich, A. Rademaker, C. Lee, J. M. Kozlowski, and J. A. Sensibar (1997). Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer. Clin. Cancer Res. 3:1707–1711.
I. Jatoi (1998). Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis. Breast Cancer Res. Treat. 52:217–225.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schedin, P., Mitrenga, T. & Kaeck, M. Estrous Cycle Regulation of Mammary Epithelial Cell Proliferation, Differentiation, and Death in the Sprague-Dawley Rat: A Model for Investigating the Role of Estrous Cycling in Mammary Carcinogenesis. J Mammary Gland Biol Neoplasia 5, 211–225 (2000). https://doi.org/10.1023/A:1026447506666
Issue Date:
DOI: https://doi.org/10.1023/A:1026447506666